The ability of the adult heart to regenerate cardio- myocytes (CMs) lost after injury is limited, generating interest in developing efficient cell-based transplantation therapies. Rigid car- bon nanotubes (CNTs) scaffolds have been used to improve CMs viability, proliferation, and maturation, but they require undesirable invasive surgeries for implantation. To overcome this limitation, we developed an injectable reverse thermal gel (RTG) functionalized with CNTs (RTG-CNT) that transitions from a solution at room temperature to a three-dimensional (3D) gel-based matrix shortly after reaching body temperature. Here we show experimental evi- dence that this 3D RTG-CNT system supports long-term CMs survival, promotes CMs alignment and proliferation, and improves CMs function when compared with traditional two-dimensional gelatin controls and 3D plain RTG system without CNTs. Therefore, our injectable RTG-CNT system could potentially be used as a minimally invasive tool for cardiac tissue engineering efforts.

Injectable Carbon Nanotube-Functionalized Reverse Thermal Gel Promotes Cardiomyocytes Survival and Maturation

BOSI, Susanna;BORIN, DANIELE;SBAIZERO, ORFEO;PRATO, MAURIZIO;
2017-01-01

Abstract

The ability of the adult heart to regenerate cardio- myocytes (CMs) lost after injury is limited, generating interest in developing efficient cell-based transplantation therapies. Rigid car- bon nanotubes (CNTs) scaffolds have been used to improve CMs viability, proliferation, and maturation, but they require undesirable invasive surgeries for implantation. To overcome this limitation, we developed an injectable reverse thermal gel (RTG) functionalized with CNTs (RTG-CNT) that transitions from a solution at room temperature to a three-dimensional (3D) gel-based matrix shortly after reaching body temperature. Here we show experimental evi- dence that this 3D RTG-CNT system supports long-term CMs survival, promotes CMs alignment and proliferation, and improves CMs function when compared with traditional two-dimensional gelatin controls and 3D plain RTG system without CNTs. Therefore, our injectable RTG-CNT system could potentially be used as a minimally invasive tool for cardiac tissue engineering efforts.
2017
Pubblicato
http://pubs.acs.org/doi/abs/10.1021/acsami.7b11438
File in questo prodotto:
File Dimensione Formato  
acsami.7b11438.pdf

Accesso chiuso

Tipologia: Documento in Versione Editoriale
Licenza: Digital Rights Management non definito
Dimensione 2.47 MB
Formato Adobe PDF
2.47 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
am7b11438_si_001supporting information.pdf

Accesso chiuso

Descrizione: supporting informations
Tipologia: Altro materiale allegato
Licenza: Digital Rights Management non definito
Dimensione 275.37 kB
Formato Adobe PDF
275.37 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2911792
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 46
social impact